Exponential Growth Ahead for Viral and Non-Viral Vector Manufacturing Market: Insights on Market Size, Key Players, and Prevailing Trends

An Emerging Force in Biotechnology: Viral and Non-Viral Vector Manufacturing Poised for Robust Growth

What Is The Projected Market Size Of The Global Viral And Non-Viral Vector Manufacturing Market And Its Growth Rate?
• The viral and non-viral vector manufacturing market has experienced rapid growth in recent years, growing from $8.67 billion in 2024 to $10.3 billion in 2025, a compound annual growth rate (CAGR) of 18.8%.
• Factors attributing to this growth include a rising prevalence of genetic disorders, advancements in biotechnology, increasing investments in gene therapy research, growing awareness of personalized medicine, and regulatory support for gene therapy development.
• The market is anticipated to see further strong growth, expanding to $22.06 billion in 2029 at a CAGR of 21.0%.
• Key factors driving forecasted growth include rising demand for gene therapies, expanding applications in rare disease treatment, increasing investments in biomanufacturing infrastructure, and growing adoption of precision medicine.

What Is Driving The Growth In The Viral And Non-Viral Vector Manufacturing Market?
The increased prevalence of genetic disorders is a critical driver for growth in the viral and non-viral vector manufacturing markets. Genetic disorders are partially or entirely caused by a variation in the typical DNA sequence. Viral vectors deliver therapeutic genes to target cells, replacing or supplementing the defective genes causing these disorders. Non-viral vectors are often employed in ex vivo gene therapy approaches where cells are genetically modified outside the body and then reintroduced into the patient. The International Diabetes Federation, for instance, reported an increase in worldwide diabetes prevalence to 10.5% in June 2022, with an expected 783 million adults, or one in eight people, anticipated to have diabetes by 2045. Thus, the increasing incidence of genetic disorders continues to propel the viral and non-viral vector manufacturing market forward.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12570&type=smp

Who Are the Key Players Driving Viral And Non-Viral Vector Manufacturing Market Growth?
• Novartis AG
• Thermo Fisher Scientific Inc.
• Merck KGaA
• FUJIFILM Holdings Corporation
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• Lonza Group AG
• WuXi AppTec Co Ltd.
• Catalent Inc.
• Sartorius AG
• Charles River Laboratories Inc.
• Sarepta Therapeutics Inc.
• GenScript ProBio Co. Ltd.
• TAKARA BIO Inc.
• Oxford BioMedica plc
• Beam Therapeutics Inc.
• Intellia Therapeutics Inc.
• MaxCyte Inc.
• Voyager Therapeutics Inc.
• Genethon
• MeiraGTx Holdings plc
• Evox Therapeutics Ltd.
• Entos Pharmaceuticals Inc.
• LogicBio Therapeutics Inc.
• bluebird bio Inc.
• 4D Molecular Therapeutics Inc.
• Precision NanoSystems Inc.
• GenSight Biologics S.A.
• Abeona Therapeutics Inc.
• Generation Bio Co.

What Are The Key Trends In The Viral And Non-Viral Vector Manufacturing Market?
• Development of next-generation viral vectors
• Increased use of CRISPR or cas9 technology in vector manufacturing
• Focus on scalable and cost-effective manufacturing processes
• Rising adoption of non-viral vectors
• Advancements in cell and gene therapy manufacturing technologies

What Are The Segments Of The Global Viral And Non-Viral Vector Manufacturing Market?
1) Vector Type: Viral Vector, Non-Viral Vector
2) Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications

Which Region Leads The Viral And Non-Viral Vector Manufacturing Market?
North America was the leading region in the viral and non-viral vector manufacturing market in 2024, with the regions covered in this market report being Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

What Is Covered In The Viral And Non-Viral Vector Manufacturing Market Global Market Report?
- Market Size Analysis: Analyze the Viral And Non-Viral Vector Manufacturing Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Viral And Non-Viral Vector Manufacturing Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Viral And Non-Viral Vector Manufacturing Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Viral And Non-Viral Vector Manufacturing Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12570&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.